Erratum: Human telomeric G-quadruplex: Targeting with small molecules (The FEBS Journal (2009))

FEBS Journal

Volumn 277, Issue 5, 2010, Pages 1345-

  Arora, Amit ^a   Kumar, Niti ^a   Agarwal, Tani ^a   Maiti, Souvik ^a  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

Author keywords

Alkaloids; Anticancer agent; Click chemistry; Ethidium derivative; G quadruplex; Human telomere; Metallo organic complex; N methylated ligands; Proto oncogenes; Telomerase

Indexed keywords

ERRATUM; PRIORITY JOURNAL; RETRACTED ARTICLE;

EID: 76349125960     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2009.07461.x     Document Type: Erratum

References (142)

1. Fry M (2007) Tetraplex DNA and its interacting proteins. Front Biosci 12, 4336 4351.
2. Maizels N (2006) Dynamic roles for G4 DNA in the biology of eukaryotic cells. Nat Struct Mol Biol 13, 1055 1059.
3. Ghosal G Muniyappa K (2006) Hoogsteen base-pairing revisited: resolving a role in normal biological processes and human diseases. Biochem Biophys Res Commun 343, 1 7.
4. Fakhoury J, Nimmo GA Autexier C (2007) Harnessing telomerase in cancer therapeutics. Anticancer Agents Med Chem 7, 475 483.
5. Kelland LR (2005) Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics: current status and future prospects. Eur J Cancer 41, 971 979.
6. Lundblad V (2002) Telomere maintenance without telomerase. Oncogene 21, 522 531.
7. Alberti P, Lacroix L, Guittat L, Helene C Mergny JL (2003) Nucleic acids as targets for antitelomerase agents. Mini Rev Med Chem 3, 23 36.
8. Dexheimer TS, Sun D Hurley LH (2006) Deconvoluting the structural and drug-recognition complexity of the G-quadruplex-forming region upstream of the bcl-2 P1 promoter. J Am Chem Soc 128, 5404 5415.
9. Izbicka E, Wheelhouse RT, Raymond E, Davidson KK, Lawrence RA, Sun D, Windle BE, Hurley LH Von Hoff DD (1999) Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells. Cancer Res 59, 639 644.
10. Kim MY, Gleason-Guzman M, Izbicka E, Nishioka D Hurley LH (2003) The different biological effects of telomestatin and TMPyP4 can be attributed to their selectivity for interaction with intramolecular or intermolecular G-quadruplex structures. Cancer Res 63, 3247 3256.
11. Liu W, Sun D Hurley LH (2005) Binding of G-quadruplex-interactive agents to distinct G-quadruplexes induces different biological effects in MiaPaCa cells. Nucleosides Nucleotides Nucleic Acids 24, 1801 1815.
12. Rangan A, Fedoroff OY Hurley LH (2001) Induction of duplex to G-quadruplex transition in the c-myc promoter region by a small molecule. J Biol Chem 276, 4640 4646.
13. Shi DF, Wheelhouse RT, Sun D Hurley LH (2001) Quadruplex-interactive agents as telomerase inhibitors: synthesis of porphyrins and structure-activity relationship for the inhibition of telomerase. J Med Chem 44, 4509 4523.
14. Siddiqui-Jain A, Grand CL, Bearss DJ Hurley LH (2002) Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription. Proc Natl Acad Sci USA 99, 11593 11598.
15. Sun D, Guo K, Rusche JJ Hurley LH (2005) Facilitation of a structural transition in the polypurine/polypyrimidine tract within the proximal promoter region of the human VEGF gene by the presence of potassium and G-quadruplex-interactive agents. Nucleic Acids Res 33, 6070 6080.
16. De AR, Wood S, Sun D, Hurley LH Ebbinghaus SW (2005) Evidence for the presence of a guanine quadruplex forming region within a polypurine tract of the hypoxia inducible factor 1alpha promoter. Biochemistry 44, 16341 16350.
17. Monchaud D, Allain C Teulade-Fichou MP (2006) Development of a fluorescent intercalator displacement assay (G4-FID) for establishing quadruplex-DNA affinity and selectivity of putative ligands. Bioorg Med Chem Lett 16, 4842 4845.
18. Ren J Chaires JB (1999) Sequence and structural selectivity of nucleic acid binding ligands. Biochemistry 38, 16067 16075.
19. Goncalves DP, Ladame S, Balasubramanian S Sanders JK (2006) Synthesis and G-quadruplex binding studies of new 4-N-methylpyridinium porphyrins. Org Biomol Chem 4, 3337 3342.
20. Goncalves DP, Rodriguez R, Balasubramanian S Sanders JK (2006) Tetramethylpyridiniumporphyrazines - a new class of G-quadruplex inducing and stabilising ligands. Chem Commun (Camb), 4685 4687. (Pubitemid 44772281)
21. Fu B, Huang J, Ren L, Weng X, Zhou Y, Du Y, Wu X, Zhou X Yang G (2007) Cationic corrole derivatives: a new family of G-quadruplex inducing and stabilizing ligands. Chem Commun (Camb), 3264 3266.
22. Rezler EM, Seenisamy J, Bashyam S, Kim MY, White E, Wilson WD Hurley LH (2005) Telomestatin and diseleno sapphyrin bind selectively to two different forms of the human telomeric G-quadruplex structure. J Am Chem Soc 127, 9439 9447.
23. Seenisamy J, Bashyam S, Gokhale V, Vankayalapati H, Sun D, Siddiqui-Jain A, Streiner N, Shin-ya K, White E, Wilson WD et al. (2005) Design and synthesis of an expanded porphyrin that has selectivity for the c-MYC G-quadruplex structure. J Am Chem Soc 127, 2944 2959.
24. Sun D, Thompson B, Cathers BE, Salazar M, Kerwin SM, Trent JO, Jenkins TC, Neidle S Hurley LH (1997) Inhibition of human telomerase by a G-quadruplex-interactive compound. J Med Chem 40, 2113 2116.
25. Perry PJ, Gowan SM, Reszka AP, Polucci P, Jenkins TC, Kelland LR Neidle S (1998) 1,4- and 2,6-disubstituted amidoanthracene-9,10-dione derivatives as inhibitors of human telomerase. J Med Chem 41, 3253 3260.
26. Perry PJ, Reszka AP, Wood AA, Read MA, Gowan SM, Dosanjh HS, Trent JO, Jenkins TC, Kelland LR Neidle S (1998) Human telomerase inhibition by regioisomeric disubstituted amidoanthracene-9,10-diones. J Med Chem 41, 4873 4884.
27. Perry PJ, Read MA, Davies RT, Gowan SM, Reszka AP, Wood AA, Kelland LR Neidle S (1999) 2,7-Disubstituted amidofluorenone derivatives as inhibitors of human telomerase. J Med Chem 42, 2679 2684. (Pubitemid 29344308)
28. Harrison RJ, Reszka AP, Haider SM, Romagnoli B, Morrell J, Read MA, Gowan SM, Incles CM, Kelland LR Neidle S (2004) Evaluation of by disubstituted acridone derivatives as telomerase inhibitors: the importance of G-quadruplex binding. Bioorg Med Chem Lett 14, 5845 5849.
29. Harrison RJ, Gowan SM, Kelland LR Neidle S (1999) Human telomerase inhibition by substituted acridine derivatives. Bioorg Med Chem Lett 9, 2463 2468.
30. Read MA, Wood AA, Harrison JR, Gowan SM, Kelland LR, Dosanjh HS Neidle S (1999) Molecular modeling studies on G-quadruplex complexes of telomerase inhibitors: structure-activity relationships. J Med Chem 42, 4538 4546.
31. Haider SM, Parkinson GN Neidle S (2003) Structure of a G-quadruplex-ligand complex. J Mol Biol 326, 117 125.
32. Moore MJ, Schultes CM, Cuesta J, Cuenca F, Gunaratnam M, Tanious FA, Wilson WD Neidle S (2006) Trisubstituted acridines as G-quadruplex telomere targeting agents. Effects of extensions of the 3, 6- and 9-side chains on quadruplex binding, telomerase activity, and cell proliferation. J Med Chem 49, 582 599.
33. Schultes CM, Guyen B, Cuesta J Neidle S (2004) Synthesis, biophysical and biological evaluation of 3,6-bis-amidoacridines with extended 9-anilino substituents as potent G-quadruplex-binding telomerase inhibitors. Bioorg Med Chem Lett 14, 4347 4351.
34. Taetz S, Baldes C, Murdter TE, Kleideiter E, Piotrowska K, Bock U, Haltner-Ukomadu E, Mueller J, Huwer H, Schaefer UF et al. (2006) Biopharmaceutical characterization of the telomerase inhibitor BRACO19. Pharm Res 23, 1031 1037.
35. Martins C, Gunaratnam M, Stuart J, Makwana V, Greciano O, Reszka AP, Kelland LR Neidle S (2007) Structure-based design of benzylamino-acridine compound as G-quadruplex DNA telomere targeting agents. Bioorg Med Chem Lett 17, 2293 2298.
36. Fedoroff OY, Salazar M, Han H, Chemeris VV, Kerwin SM Hurley LH (1998) NMR-based model of a telomerase-inhibiting compound bound to G-quadruplex DNA. Biochemistry 37, 12367 12374.
37. Kern JT Kerwin SM (2002) The aggregation and G-quadruplex DNA selectivity of charged 3,4,9,10-perylenetetracarboxylic acid diimides. Bioorg Med Chem Lett 12, 3395 3398.
38. Kern JT, Thomas PW Kerwin SM (2002) The relationship between ligand aggregation and G-quadruplex DNA selectivity in a series of 3,4,9,10- perylenetetracarboxylic acid diimides. Biochemistry 41, 11379 11389.
39. Mazzitelli CL, Brodbelt JS, Kern JT, Rodriguez M Kerwin SM (2006) Evaluation of binding of perylene diimide and benzannulated perylene diimide ligands to DNA by electrospray ionization mass spectrometry. J Am Soc Mass Spectrom 17, 593 604.
40. Duan W, Rangan A, Vankayalapati H, Kim MY, Zeng Q, Sun D, Han H, Fedoroff OY, Nishioka D, Rha SY et al. (2001) Design and synthesis of fluoroquinophenoxazines that interact with human telomeric G-quadruplexes and their biological effects. Mol Cancer Ther 1, 103 120.
41. Mehta AK, Shayo Y, Vankayalapati H, Hurley LH Schaefer J (2004) Structure of a quinobenzoxazine-G-quadruplex complex by REDOR NMR. Biochemistry 43, 11953 11958.
42. Clark GR, Pytel PD, Squire CJ Neidle S (2003) Structure of the first parallel DNA quadruplex-drug complex. J Am Chem Soc 125, 4066 4067.
43. 1H-NMR study. Nucleosides Nucleotides Nucleic Acids 21, 535 545.
44. Li W, Zhang M, Zhang JL, Li HQ, Zhang XC, Sun Q Qiu CM (2006) Interactions of daidzin with intramolecular G-quadruplex. FEBS Lett 580, 4905 4910.
45. Sun H, Tang Y, Xiang J, Xu G, Zhang Y, Zhang H Xu L (2006) Spectroscopic studies of the interaction between quercetin and G-quadruplex DNA. Bioorg Med Chem Lett 16, 3586 3589. (Pubitemid 43777091)
46. Brassart B, Gomez D, De CA, Paterski R, Montagnac A, Qui KH, Temime-Smaali N, Trentesaux C, Mergny JL, Gueritte F et al. (2007) A new steroid derivative stabilizes G-quadruplexes and induces telomere uncapping in human tumor cells. Mol Pharmacol 72, 631 640.
47. Kelland L (2007) Targeting the limitless replicative potential of cancer: the telomerase/telomere pathway. Clin Cancer Res 13, 4960 4963.
48. Leonetti C, Scarsella M, Riggio G, Rizzo A, Salvati E, D'Incalci M, Staszewsky L, Frapolli R, Stevens MF, Stoppacciaro A et al. (2008) G-quadruplex ligand RHPS4 potentiates the antitumor activity of camptothecins in preclinical models of solid tumors. Clin Cancer Res 14, 7284 7291.
49. Mergny JL, Lacroix L, Teulade-Fichou MP, Hounsou C, Guittat L, Hoarau M, Arimondo PB, Vigneron JP, Lehn JM, Riou JF et al. (2001) Telomerase inhibitors based on quadruplex ligands selected by a fluorescence assay. Proc Natl Acad Sci USA 98, 3062 3067.
50. Hounsou C, Guittat L, Monchaud D, Jourdan M, Saettel N, Mergny JL Teulade-Fichou MP (2007) G-quadruplex recognition by quinacridines: a SAR, NMR, and biological study. ChemMedChem 2, 655 666.
51. Allain C, Monchaud D Teulade-Fichou MP (2006) FRET templated by G-quadruplex DNA: a specific ternary interaction using an original pair of donor/acceptor partners. J Am Chem Soc 128, 11890 11893.
52. Gabelica V, Baker ES, Teulade-Fichou MP, De PE Bowers MT (2007) Stabilization and structure of telomeric and c-myc region intramolecular G-quadruplexes: the role of central cations and small planar ligands. J Am Chem Soc 129, 895 904.
53. Teulade-Fichou MP, Carrasco C, Guittat L, Bailly C, Alberti P, Mergny JL, David A, Lehn JM Wilson WD (2003) Selective recognition of G-quadruplex telomeric DNA by a bis(quinacridine) macrocycle. J Am Chem Soc 125, 4732 4740.
54. Alberti P, Schmitt P, Nguyen CH, Rivalle C, Hoarau M, Grierson DS Mergny JL (2002) Benzoindoloquinolines interact with DNA tetraplexes and inhibit telomerase. Bioorg Med Chem Lett 12, 1071 1074.
55. Caprio V, Guyen B, Opoku-Boahen Y, Mann J, Gowan SM, Kelland LM, Read MA Neidle S (2000) A novel inhibitor of human telomerase derived from 10H-indolo[3,2-b]quinoline. Bioorg Med Chem Lett 10, 2063 2066.
56. Guyen B, Schultes CM, Hazel P, Mann J Neidle S (2004) Synthesis and evaluation of analogues of 10H-indolo[3,2-b]quinoline as G-quadruplex stabilising ligands and potential inhibitors of the enzyme telomerase. Org Biomol Chem 2, 981 988.
57. Guittat L, Alberti P, Rosu F, Van MS, Thetiot E, Pieters L, Gabelica V, De PE, Ottaviani A, Riou JF et al. (2003) Interactions of cryptolepine and neocryptolepine with unusual DNA structures. Biochimie 85, 535 547.
58. Liu JN, Deng R, Guo JF, Zhou JM, Feng GK, Huang ZS, Gu LQ, Zeng YX Zhu XF (2007) Inhibition of myc promoter and telomerase activity and induction of delayed apoptosis by SYUIQ-5, a novel G-quadruplex interactive agent in leukemia cells. Leukemia 21, 1300 1302.
59. Ou TM, Lu YJ, Zhang C, Huang ZS, Wang XD, Tan JH, Chen Y, Ma DL, Wong KY, Tang JC et al. (2007) Stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc by quindoline derivatives. J Med Chem 50, 1465 1474.
60. Zhou JL, Lu YJ, Ou TM, Zhou JM, Huang ZS, Zhu XF, Du CJ, Bu XZ, Ma L, Gu LQ et al. (2005) Synthesis and evaluation of quindoline derivatives as G-quadruplex inducing and stabilizing ligands and potential inhibitors of telomerase. J Med Chem 48, 7315 7321.
61. Zhou JM, Zhu XF, Lu YJ, Deng R, Huang ZS, Mei YP, Wang Y, Huang WL, Liu ZC, Gu LQ et al. (2006) Senescence and telomere shortening induced by novel potent G-quadruplex interactive agents, quindoline derivatives, in human cancer cell lines. Oncogene 25, 503 511.
62. Hooda J, Bednarski D, Irish L Firestine SM (2006) Synthesis and testing of a triaza-cyclopenta[b]phenanthrene scaffold as a DNA binding agent. Bioorg Med Chem 14, 1902 1909.
63. Arora A, Balasubramanian C, Kumar N, Agrawal S, Ojha RP Maiti S (2008) Binding of berberine to human telomeric quadruplex - spectroscopic, calorimetric and molecular modeling studies. FEBS J 275, 3971 3983.
64. Zhang WJ, Ou TM, Lu YJ, Huang YY, Wu WB, Huang ZS, Zhou JL, Wong KY Gu LQ (2007) 9-Substituted berberine derivatives as G-quadruplex stabilizing ligands in telomeric DNA. Bioorg Med Chem 15, 5493 5501.
65. Franceschin M, Rossetti L, D'Ambrosio A, Schirripa S, Bianco A, Ortaggi G, Savino M, Schultes C Neidle S (2006) Natural and synthetic G-quadruplex interactive berberine derivatives. Bioorg Med Chem Lett 16, 1707 1711.
66. Tan JH, Ou TM, Hou JQ, Lu YJ, Huang SL, Luo HB, Wu JY, Huang ZS, Wong KY Gu LQ (2009) Isaindigotone derivatives: a new class of highly selective ligands for telomeric G-quadruplex DNA. J Med Chem 52, 2825 2835.
67. Li Q, Xiang J, Li X, Xu X, Tang Y, Zhou Q, Li L, Zhang H, Sun H, Guan A et al. (2009) Stabilizing parallel G-quadruplex DNA by a new class of ligands: two non-planar alkaloids through interaction in lateral grooves. Biochimie 91, 811 819.
68. Moorhouse AD, Santos AM, Gunaratnam M, Moore M, Neidle S Moses JE (2006) Stabilization of G-quadruplex DNA by highly selective ligands via click chemistry. J Am Chem Soc 128, 15972 15973.
69. Kaiser M, De CA, Sainlos M, Renner C, Mergny JL Teulade-Fichou MP (2006) Neomycin-capped aromatic platforms: quadruplex DNA recognition and telomerase inhibition. Org Biomol Chem 4, 1049 1057.
70. Jantos K, Rodriguez R, Ladame S, Shirude PS Balasubramanian S (2006) Oxazole-based peptide macrocycles: a new class of G-quadruplex binding ligands. J Am Chem Soc 128, 13662 13663. (Pubitemid 44632826)
71. Bejugam M, Sewitz S, Shirude PS, Rodriguez R, Shahid R Balasubramanian S (2007) Trisubstituted isoalloxazines as a new class of G-quadruplex binding ligands: small molecule regulation of c-kit oncogene expression. J Am Chem Soc 129, 12926 12927.
72. Drewe WC Neidle S (2008) Click chemistry assembly of G-quadruplex ligands incorporating a diarylurea scaffold and triazole linkers. Chem Commun (Camb), 5295 5297.
73. Drewe WC, Nanjunda R, Gunaratnam M, Beltran M, Parkinson GN, Reszka AP, Wilson WD Neidle S (2008) Rational design of substituted diarylureas: a scaffold for binding to G-quadruplex motifs. J Med Chem 51, 7751 7767.
74. Redman JE, Granadino-Roldán JM, Schouten JA, Ladame S, Reszka AP, Neidle S Balasubramanian S (2009) Recognition and discrimination of DNA quadruplexes by acridine-peptide conjugates. Org Biomol Chem 7, 76 84.
75. Chakraborty TK, Arora A, Roy S, Kumar N Maiti S (2007) Furan based cyclic oligopeptides selectively target G-quadruplex. J Med Chem 50, 5539 5542.
76. Koeppel F, Riou JF, Laoui A, Mailliet P, Arimondo PB, Labit D, Petitgenet O, Helene C Mergny JL (2001) Ethidium derivatives bind to G-quartets, inhibit telomerase and act as fluorescent probes for quadruplexes. Nucleic Acids Res 29, 1087 1096.
77. Gomez D, Aouali N, Londono-Vallejo A, Lacroix L, Megnin-Chanet F, Lemarteleur T, Douarre C, Shin-ya K, Mailliet P, Trentesaux C et al. (2003) Resistance to the short term antiproliferative activity of the G-quadruplex ligand 12459 is associated with telomerase overexpression and telomere capping alteration. J Biol Chem 278, 50554 50562.
78. Gomez D, Lemarteleur T, Lacroix L, Mailliet P, Mergny JL Riou JF (2004) Telomerase downregulation induced by the G-quadruplex ligand 12459 in A549 cells is mediated by hTERT RNA alternative splicing. Nucleic Acids Res 32, 371 379.
79. Riou JF, Guittat L, Mailliet P, Laoui A, Renou E, Petitgenet O, Megnin-Chanet F, Helene C Mergny JL (2002) Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands. Proc Natl Acad Sci USA 99, 2672 2677.
80. Lemarteleur T, Gomez D, Paterski R, Mandine E, Mailliet P Riou JF (2004) Stabilization of the c-myc gene promoter quadruplex by specific ligands' inhibitors of telomerase. Biochem Biophys Res Commun 323, 802 808.
81. Pennarun G, Granotier C, Gauthier LR, Gomez D, Hoffschir F, Mandine E, Riou JF, Mergny JL, Mailliet P Boussin FD (2005) Apoptosis related to telomere instability and cell cycle alterations in human glioma cells treated by new highly selective G-quadruplex ligands. Oncogene 24, 2917 2928.
82. Granotier C, Pennarun G, Riou L, Hoffschir F, Gauthier LR, De CA, Gomez D, Mandine E, Riou JF, Mergny JL et al. (2005) Preferential binding of a G-quadruplex ligand to human chromosome ends. Nucleic Acids Res 33, 4182 4190.
83. De CA Mergny JL (2007) Quadruplex ligands may act as molecular chaperones for tetramolecular quadruplex formation. Nucleic Acids Res 35, 2483 2493.
84. De CA, Cristofari G, Reichenbach P, De LE, Monchaud D, Teulade-Fichou MP, Shin-ya K, Lacroix L, Lingner J Mergny JL (2007) Reevaluation of telomerase inhibition by quadruplex ligands and their mechanisms of action. Proc Natl Acad Sci USA 104, 17347 17352.
85. De CA, Delemos E, Mergny JL, Teulade-Fichou MP Monchaud D (2007) Highly efficient G-quadruplex recognition by bisquinolinium compounds. J Am Chem Soc 129, 1856 1857.
86. Evans SE, Mendez MA, Turner KB, Keating LR, Grimes RT, Melchoir S Szalai VA (2007) End-stacking of copper cationic porphyrins on parallel-stranded guanine quadruplexes. J Biol Inorg Chem 12, 1235 1249.
87. Keating LR Szalai VA (2004) Parallel-stranded guanine quadruplex interactions with a copper cationic porphyrin. Biochemistry 43, 15891 15900.
88. Dixon IM, Lopez F, Tejera AM, Esteve JP, Blasco MA, Pratviel G Meunier B (2007) A G-quadruplex ligand with 10000-fold selectivity over duplex DNA. J Am Chem Soc 129, 1502 1503.
89. Bertrand H, Monchaud D, De CA, Guillot R, Mergny JL Teulade-Fichou MP (2007) The importance of metal geometry in the recognition of G-quadruplex-DNA by metal-terpyridine complexes. Org Biomol Chem 5, 2555 2559.
90. Ma DL, Che CM Yan SC (2009) Platinum(II) complexes with dipyridophenazine ligands as human telomerase inhibitors and luminescent probes for G-quadruplex DNA. J Am Chem Soc 131, 1835 1846.
91. Shin-ya K, Wierzba K, Matsuo K, Ohtani T, Yamada Y, Furihata K, Hayakawa Y Seto H (2001) Telomestatin, a novel telomerase inhibitor from Streptomyces anulatus. J Am Chem Soc 123, 1262 1263.
92. Binz N, Shalaby T, Rivera P, Shin-ya K Grotzer MA (2005) Telomerase inhibition, telomere shortening, cell growth suppression and induction of apoptosis by telomestatin in childhood neuroblastoma cells. Eur J Cancer 41, 2873 2881.
93. Gomez D, O'Donohue MF, Wenner T, Douarre C, Macadre J, Koebel P, Giraud-Panis MJ, Kaplan H, Kolkes A, Shin-ya K et al. (2006) The G-quadruplex ligand telomestatin inhibits POT1 binding to telomeric sequences in vitro and induces GFP-POT1 dissociation from telomeres in human cells. Cancer Res 66, 6908 6912.
94. Gomez D, Paterski R, Lemarteleur T, Shin-ya K, Mergny JL Riou JF (2004) Interaction of telomestatin with the telomeric single-strand overhang. J Biol Chem 279, 41487 41494.
95. Gomez D, Wenner T, Brassart B, Douarre C, O'Donohue MF, El Khoury V, Shin-ya K, Morjani H, Trentesaux C Riou JF (2006) Telomestatin-induced telomere uncapping is modulated by POT1 through G-overhang extension in HT1080 human tumor cells. J Biol Chem 281, 38721 38729.
96. Kim MY, Vankayalapati H, Shin-ya K, Wierzba K Hurley LH (2002) Telomestatin, a potent telomerase inhibitor that interacts quite specifically with the human telomeric intramolecular G-quadruplex. J Am Chem Soc 124, 2098 2099.
97. Rosu F, Gabelica V, Shin-ya K De PE (2003) Telomestatin-induced stabilization of the human telomeric DNA quadruplex monitored by electrospray mass spectrometry. Chem Commun (Camb), 2702 2703.
98. Tahara H, Shin-ya K, Seimiya H, Yamada H, Tsuruo T Ide T (2006) G-Quadruplex stabilization by telomestatin induces TRF2 protein dissociation from telomeres and anaphase bridge formation accompanied by loss of the 3′ telomeric overhang in cancer cells. Oncogene 25, 1955 1966.
99. Tauchi T, Shin-ya K, Sashida G, Sumi M, Okabe S, Ohyashiki JH Ohyashiki K (2006) Telomerase inhibition with a novel G-quadruplex-interactive agent, telomestatin: in vitro and in vivo studies in acute leukemia. Oncogene 25, 5719 5725.
100. Doi T, Yoshida M, Shin-ya K Takahashi T (2006) Total synthesis of (R) - telomestatin. Org Lett 8, 4165 4167.
101. Satyanarayana M, Rzuczek SG, Lavoie EJ, Pilch DS, Liu A, Liu LF Rice JE (2008) Ring-closing metathesis for the synthesis of a highly G-quadruplex selective macrocyclic hexaoxazole having enhanced cytotoxic potency. Bioorg Med Chem Lett 18, 3802 3804.
102. Pilch DS, Barbieri CM, Rzuczek SG, Lavoie EJ Rice JE (2008) Targeting human telomeric G-quadruplex DNA with oxazole-containing macrocyclic compounds. Biochimie 90, 1233 1249.
103. Barbieri CM, Srinivasan AR, Rzuczek SG, Rice JE, LaVoie EJ Pilch DS (2007) Defining the mode, energetics and specificity with which a macrocyclic hexaoxazole binds to human telomeric G-quadruplex DNA. Nucleic Acids Res 35, 3272 3286.
104. Hanahan D Weinberg RA (2000) The hallmarks of cancer. Cell 100, 57 70.
105. Mergny JL, Riou JF, Mailliet P, Teulade-Fichou MP Gilson E (2002) Natural and pharmacological regulation of telomerase. Nucleic Acids Res 30, 839 865.
106. Mergny JL Hélène C (1998) DNA G-quadruplex, a target for drug design. Nat Med 4, 1366 1367.
107. Mergny JL, Mailliet P, Lavelle F, Riou JF, Laoui A Hélène C (1999) The development of telomerase inhibitors: the G-quartet approach. Anti Cancer Drug Des 14, 327 339.
108. Cohen SB, Graham ME, Lovrecz GO, Bache N, Robinson PJ Reddel RR (2007) Protein composition of catalytically active human telomerase from immortal cells. Science 315, 1850 1853.
109. Renaud S, Loukinov D, Abdullaev Z, Guilleret I, Bosman FT, Lobanenkov V Benhattar J (2007) Dual role of DNA methylation inside and outside of CTCF-binding regions in the transcriptional regulation of the telomerase hTERT gene. Nucleic Acids Res 35, 1245 1256.
110. Sikand K, Kaul D Varma N (2006) Receptor Ck-dependent signaling regulates hTERT gene transcription. BMC Cell Biol 7, 2.
111. Zhao JQ, Bilsland A, Hoare SF Keith WN (2003) Involvement of NF-Y and Sp1 binding sequences in basal transcription of the human telomerase RNA gene. FEBS Lett 536, 111 119.
112. Bilsland AE, Stevenson K, Atkinson S, Kolch W Keith WN (2006) Transcriptional repression of telomerase RNA gene expression by c-Jun-NH2-kinase and Sp1/Sp3. Cancer Res 66, 1363 1370.
113. Liu D, O'Connor MS, Qin J Songyang Z (2004) Telosome, a mammalian telomere-associated complex formed by multiple telomeric proteins. J Biol Chem 279, 51338 51342.
114. de Lange T (2005) Shelterin: the protein complex that shapes and safeguards telomeres. Genes Dev 19, 2100 2110.
115. Court R, Chapman L, Fairall L Rhodes D (2005) How the human telomeric proteins TRF1 and TRF2 recognize telomeric DNA: a view from high resolution structures. EMBO Rep 6, 39 45.
116. Lei M, Podell ER Cech TR (2004) Structure of human POT1 bound to telomeric single-stranded DNA provides a model for chromosome end-protection. Nat Struct Mol Biol 11, 1223 1229.
117. O'Connor MS, Safari A, Xin H, Liu D Songyang Z (2006) A critical role for TPP1 and TIN2 interaction in high-order telomeric complex assembly. Proc Natl Acad Sci USA 103, 11874 11879.
118. Griffith JD, Comeau L, Rosenfield S, Stansel RM, Bianchi A, Moss H de Lange T (1999) Mammalian telomeres end in a large duplex loop. Cell 97, 503 514.
119. Stansel RM, de Lange T Griffith JD (2001) T-loop assembly in vitro involves binding of TRF2 near the 3′ telomeric overhang. EMBO J 20, 5532 5540.
120. Blanco R, Munoz P, Flores JM, Klatt P Blasco MA (2007) Telomerase abrogation dramatically accelerates TRF2-induced epithelial carcinogenesis. Genes Dev 21, 206 220.
121. Richter T, Saretzki G, Nelson G, Melcher M, Olijslagers S Zglinicki von T (2007) TRF2 over expression diminishes repair of telomeric single strand breaks and accelerates telomere shortening in human fibroblasts. Mech Ageing Dev 128, 340 345.
122. Xin H, Liu D, Wan M, Safari A, Kim H, Sun W, O'Connor MS Songyang Z (2007) TPP1 is a homologue of ciliate TEBP-beta and interacts with POT1 to recruit telomerase. Nature 445, 559 562.
123. Wang F, Podell ER, Zaug AJ, Yang Y, Baciu P, Cech TR Lei M (2007) The POT1-TPP1 telomere complex is a telomerase processivity factor. Nature 445, 506 510.
124. Lenain C, Bauwens S, Amiard S, Brunori M, Giraud-Panis MJ Gilson E (2006) The Apollo 5′ exonuclease functions together with TRF2 to protect telomeres from DNA repair. Curr Biol 16, 1303 1310.
125. van Overbeek M de Lange T (2006) Apollo, an Artemis-related nuclease, interacts with TRF2 and protects human telomeres in S phase. Curr Biol 16, 1295 1302.
126. Hockemeyer D, Sfeir AJ, Shay JW, Wright WE de Lange T (2005) POT1 protects telomeres from a transient DNA damage response and determines how human chromosomes end. EMBO J 24, 2667 2678.
127. Zhu XD, Niedernhofer L, Kuster B, Mann M, Hoeijmakers JHJ de Lange T (2003) ERCC1/XPF removes the 3′ overhang from uncapped telomeres and represses formation of telomeric DNA-containing double minute chromosomes. Mol Cell 12, 1489 1498.
128. He H, Multani AS, Cosme-Blanco W, Tahara H, Ma J, Pathak S, Deng Y Chang S (2006) POT1b protects telomeres from end-to-end chromosomal fusions and aberrant homologous recombination. EMBO J 25, 5180 5190.
129. Celli GB de Lange T (2005) DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion. Nat Cell Biol 7, 712 718.
130. Hahn WC, Stewart SA, Brooks MW, York SG, Eaton E, Kurachi A, Beijersbergen RL, Knoll JHM, Meyerson M Weinberg RA (1999) Inhibition of telomerase limits the growth of human cancer cells. Nat Med 5, 1164 1170.
131. Tauchi T, Shinya K, Sashida G, Sumi M, Nakajima A, Shimamoto T, Ohyashiki JH Ohyashiki K (2003) Activity of a novel G quadruplex-interactive telomerase inhibitor, telomestatin (SOT-095), against human leukemia cells: involvement of ATM-dependent DNA damage response pathways. Oncogene 22, 5338 5347.
132. Shammas MA, Reis RJS, Akiyama M, Koley H, Chauhan D, Hideshima T, Goyal RK, Hurley LH, Anderson KC Munshi NC (2003) Telomerase inhibition and cell growth arrest by G-quadruplex interactive agent in multiple myeloma. Mol Cancer Ther 2, 825 833.
133. Burger AM, Dai FP, Schultes CM, Reszka AP, Moore MJ, Double JA Neidle S (2005) The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function. Cancer Res 65, 1489 1496.
134. Gowan SM, Harrison JR, Patterson L, Valenti M, Read MA, Neidle S Kelland LR (2002) A G-quadruplex-interactive potent small-molecule inhibitor of telomerase exhibiting in vitro and in vivo antitumour activity. Mol Pharmacol 61, 1154 1162.
135. Gowan SM, Heald R, Stevens M Kelland LR (2001) Potent inhibition of telomerase by small-molecule pentacyclic acridines capable of interacting with G-quadruplexes. Mol Pharmacol 60, 981 988.
136. Incles CM, Schultes CM, Kempski H, Koehler H, Kelland LR Neidle S (2004) A G-quadruplex telomere targeting agent produces p16-associated senescence and chromosomal fusions in human prostate cancer cells. Mol Cancer Ther 3, 1201 1206.
137. Gomez D, Aouali N, Renaud A, Douarre C, Shinya K, Tazi J, Martinez S, Trentesaux C, Morjani H Riou JF (2003) Resistance to senescence induction and telomere shortening by a G-quadruplex ligand inhibitor of telomerase. Cancer Res 63, 6149 6153.
138. Leonetti C, Amodei S, DAngelo C, Rizzo A, Benassi B, Antonelli A, Elli R, Stevens MFG, DIncalci M, Zupi G et al. (2004) Biological activity of the G-quadruplex ligand RHPS4 (3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl] acridinium methosulfate) is associated with telomere capping alteration. Mol Pharmacol 66, 1138 1146.
139. Karlseder J, Broccoli D, Dai YM, Hardy S de Lange T (1999) p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 283, 1321 1325.
140. Phatak P, Cookson JC, Dai F, Smith V, Gartenhaus RB, Stevens MF Burger AM (2007) Telomere uncapping by the G-quadruplex ligand RHPS4 inhibits clonogenic tumour cell growth in vitro and in vivo consistent with a cancer stem cell targeting mechanism. Br J Cancer 96, 1223 1233.
141. Douarre C, Gomez D, Morjani H, Zahm JM, O'Donohue MF, Eddabra L, Mailliet P, Riou JF Trentesaux C (2005) Over expression of Bcl-2 is associated with apoptotic resistance to the G-quadruplex ligand 12459 but is not sufficient to confer resistance to long-term senescence. Nucleic Acids Res 33, 2192 2203.
142. Campbell NH, Patel M, Tofa AB, Ghosh R, Parkinson GN Neidle S (2009) Selectivity in ligand recognition of G-quadruplex loops (dagger). Biochemistry 48, 1675 1680.